Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
24.0%
% of FTXH's 51 holdings also in CANC
25.0%
% of CANC's 48 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 6.6% | 4.4% | 4.4% |
|
ELI LILLY & CO | 3.3% | 4.7% | 3.3% |
|
AMGEN INC | 3.1% | 2.9% | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 8.8% | 2.0% | 2.0% |
|
ABBVIE INC | 7.0% | 2.0% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to CANC
|
PFIZER INC | 7.3% |
|
BRISTOL-MYERS SQUIBB CO | 6.8% |
|
JOHNSON & JOHNSON | 6.7% |
|
ABBVIE INC | 5.0% |
|
CARDINAL HEALTH INC | 4.2% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
VIATRIS, INC. | 3.8% |
|
ZOETIS INC | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
BIOGEN IDEC INC | 2.9% |
FTXH Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.9% |
|
REVOLUTION MEDICINES, INC. | -4.3% |
|
BRIDGEBIO PHARMA, INC. | -4.1% |
 |
GENMAB A/S SPONSORED ADR | -4.1% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.6% |
|
NOVARTIS AG | -3.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.0% |
|
DAIICHI SANKYO CO LTD | -2.9% |
|
NUVALENT, INC. CLASS A | -2.8% |
|
BEIGENE LTD. SPONSORED ADR | -2.8% |